Core Scientific upgraded on its uncontracted power capacity
Market Intelligence Analysis
AI-Powered 80% GROQ-LLAMA-3.1-8B-INSTANTRoth MKM upgraded Core Scientific to Buy, expecting the merger with CoreWeave to be rejected without renegotiation, citing growing shareholder opposition and proxy advisers' recommendations against the deal.
Positive, as the upgrade and increased price target of $23.50 may lead to a short-term increase in Core Scientific's stock price, potentially benefiting investors who hold the stock.
Article Context
Investing.com --Roth MKM upgraded Core Scientific to Buy saying it now expects the data center operator’s merger with CoreWeave to be rejected without renegotiation and sees value in its uncontracted power capacity.Roth lifted its price target to $23.50 from $17. There is growing shareholder opposition against deal and CoreWeave’s insistence that its offer was “best and final” have made the deal unlikely to close. Proxy advisers Glass Lewis and ISS have also recommended against it. The firms are
AI Breakdown
Summary
Roth MKM upgraded Core Scientific to Buy, expecting the merger with CoreWeave to be rejected without renegotiation, citing growing shareholder opposition and proxy advisers' recommendations against the deal.
Market Impact
Positive, as the upgrade and increased price target of $23.50 may lead to a short-term increase in Core Scientific's stock price, potentially benefiting investors who hold the stock.
Analysis and insights provided by AnalystMarkets AI.